U.S. Capital Markets Stock News

Wondering whether Amprius Technologies at US$21.40 is still worth your attention after a rapid run up, or if the price has already moved ahead of the fundamentals? The stock has returned 8.7% over the last week, 33.8% over the last month, 144.9% year to date, and a very large 1 year return of 822.4%, which puts recent trading firmly on most investors' radar. Recent coverage has focused on Amprius Technologies as interest in battery and electrification related companies has increased, with...

First Bancorp recently reported first-quarter 2026 results, with net interest income rising to US$107.12 million and net income to US$46.66 million, while also disclosing US$1.40 million in net charge-offs for the period. The bank also strengthened its governance and industry expertise by adding alternative-investments specialist Kate Nevin and higher-education leader Peter Hans to its Board of Directors. With earnings growth and expanded board expertise in focus, we’ll now examine how these...

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...

Tronox Holdings plc recently confirmed a quarterly dividend of US$0.0500 per share payable on July 8, 2026, with both the ex-dividend and record dates set in the past on May 11, 2026. Around the same time, Truist downgraded Tronox to Sell, highlighting concerns about cost pressures and near-term earnings guidance despite the dividend affirmation. With Truist’s downgrade foregrounding near-term earnings pressures, we’ll now examine how this development reshapes Tronox’s existing investment...

Heartland Express, Inc. previously reported first-quarter 2026 results showing sales of US$176.26 million versus US$219.42 million a year earlier, with net loss narrowing to US$4.82 million and no share repurchases during the period under its existing buyback programs. Alongside the smaller loss, investors also learned that long-time executive David P. Millis retired as President of Millis Transfer while remaining on Heartland’s board, a leadership shift that may influence how integration...

Stock performance snapshot and why FTI Consulting is on investors’ radar FTI Consulting (FCN) has drawn investor attention after recent price moves, with the stock closing at US$166.95. Returns over the past week, month and past 3 months have all been negative. See our latest analysis for FTI Consulting. The recent pullback, including a 1-day share price return of negative 0.65% and a 30-day share price return of negative 8.93%, sits against a 5-year total shareholder return of 17.65%. This...

Supernus Pharmaceuticals (SUPN) is back in focus after reporting first quarter 2026 results that topped Wall Street earnings and revenue expectations, with Qelbree, GOCOVRI, ZURZUVAE, and ONAPGO playing key roles. See our latest analysis for Supernus Pharmaceuticals. Supernus Pharmaceuticals’ share price has been broadly steady in recent months, with a 2.7% 1 month share price decline and a roughly flat 90 day move. However, a 59.0% 1 year total shareholder return points to strong longer term...

Why Broadcom Stock Is Back in Focus Broadcom (AVGO) is drawing fresh attention after a strong run over the past month and past 3 months, prompting investors to reassess how its current valuation lines up with its growth profile. See our latest analysis for Broadcom. At a share price of $427.36, Broadcom has seen strong momentum recently, with a 30 day share price return of 35.92% adding to a very large 5 year total shareholder return. This keeps the current valuation firmly in the spotlight...

Context for Ross Stores stock Ross Stores (ROST) has drawn investor attention recently as its stock screens show a market value of about US$72.8b and reported annual revenue of US$22.8b with net income of US$2.1b. See our latest analysis for Ross Stores. The share price has gained clear traction recently, with a 20.16% 90 day share price return and 24.45% year to date, while the 1 year total shareholder return of 62.2% points to strong, sustained momentum. If Ross Stores strong run has you...

Why Onto Innovation Is Drawing Fresh Attention Recent trading in Onto Innovation (ONTO) has turned heads, with the stock showing strong gains over the past month and past 3 months, prompting investors to reassess its semiconductor equipment exposure. See our latest analysis for Onto Innovation. That recent strength is part of a longer run, with a 30 day share price return of 41.51% and a 1 year total shareholder return of 149.14%, pointing to strong momentum rather than a short lived...

Event context and recent stock performance Flutter Entertainment (NYSE:FLUT) has drawn attention after a period of weak returns, with the stock down about 1% over the past week, 3% over the past month and 33% over the past 3 months. See our latest analysis for Flutter Entertainment. At a share price of $103.33, Flutter’s recent pressure has been pronounced, with a 90 day share price return of 33% and a 1 year total shareholder return of 58%. This suggests momentum has been fading as investors...

If you are wondering whether PulteGroup is reasonably priced or starting to look stretched, it helps to line up what the current share price is implying about the business. The stock recently closed at US$117.97, with returns of 17.9% over 1 year, 78.2% over 3 years and 107.9% over 5 years. The year to date move of 0.6% and a 7 day return of a 5.6% decline hint at shifting expectations around future risks and rewards. Recent coverage has focused on how homebuilding stocks like PulteGroup...

Event driven snapshot of Acadia Healthcare Company (ACHC) Acadia Healthcare Company (ACHC) shares have been volatile recently, with a 9% decline over the past week offset by gains of about 5% over the month and roughly 86% in the past 3 months. See our latest analysis for Acadia Healthcare Company. At a share price of $25.27, Acadia Healthcare Company's recent share price return shows sharp short term swings but strong recent momentum, with a 5.47% 30 day gain and 86.49% 90 day gain. This...

If you are wondering whether Keysight Technologies at around US$355.93 is a bargain or already pricing in a lot of optimism, the starting point is to understand what the current valuation is actually implying. The stock has shown strong recent momentum, with returns of 7.1% over 7 days, 22.2% over 30 days, 72.3% year to date, 142.9% over 1 year, 148.9% over 3 years and 156.2% over 5 years. This naturally raises questions about how much upside or risk is now baked into the price. Recent...

Constellation Brands recently completed a US$499.72 million fixed-income offering of 4.850% senior unsecured notes due May 6, 2031, while also launching Modelo Chelada Suprema, its first high-ABV ready-to-drink beer-based product, nationwide in 24-ounce cans and two fruit flavors. The Modelo Chelada Suprema launch directly targets Gen Z and Millennial demand for higher-proof, internationally inspired flavors, reinforcing Constellation Brands’ push deeper into the growing ready-to-drink and...

AAR’s new commercial distribution role with Woodward AAR (AIR) has signed a multi year commercial distribution agreement with Woodward, making AAR the preferred distributor of high demand consumable engine parts for airlines using CFM LEAP, GEnx, and CF34 engines. See our latest analysis for AAR. AAR’s share price return has been strong, with a year to date gain of 32.5% and a 1 year total shareholder return of 90.37%. This suggests momentum has been building around the stock as the Woodward...

CleanSpark (NasdaqCM:CLSK) is accelerating a shift from pure Bitcoin mining toward hosting AI and high performance computing data centers. The company is in advanced talks with a potential investment grade hyperscaler tenant for direct data center capacity. New greenfield AI data center construction is underway in Georgia, backed by CleanSpark’s existing power portfolio. Management is publicly addressing concerns around data center power and water usage as part of this transition. For you...

Amgen (NasdaqGS:AMGN) has been selected by the FDA as one of only two companies to run proof of concept trials under the new real time clinical trials initiative. The program is designed to enable continuous clinical development with real time data sharing between companies and the FDA. The collaboration focuses on reshaping how trials are designed, monitored, and adapted during the development of new therapies. Amgen is a large biotechnology company with a broad portfolio of therapies and...

In early May 2026, Entergy Corporation filed a follow-on equity offering of US$2.18 billion in common stock, shortly after reporting first-quarter 2026 revenue of US$3,187.63 million and net income of US$384.92 million. An interesting aspect is that Entergy is seeking to raise a very large amount of new equity just days after posting higher year-on-year sales and net income, which may influence how investors view its capital needs and future projects. We’ll now examine how this sizable...

Investors may be wondering if Prudential Financial at around US$100 a share still offers value, or if most of the opportunity has already been priced in. The stock last closed at US$100.27, with returns of 3.5% over the past week, 2.8% over the past month, 3.7% over the last year and 43.0% over three years. Year to date it is down 11.9% and up 21.6% over five years. Recent headlines have focused on Prudential Financial in the context of broader insurance sector sentiment and changing...

If you are wondering whether Walt Disney stock at around US$100 is offering value or just nostalgia, you are not alone. That is exactly what this breakdown will tackle. The share price last closed at US$100.48, with a 1% decline over the last 7 days, a 4% gain over 30 days, a 10.2% year to date decline, a 10.2% return over 1 year, a 0.7% return over 3 years and a 43.4% decline over 5 years. Recent headlines have focused on Disney's ongoing business reshaping, including its continued push...

Dentsply Sirona has reported Q1 2026 results showing essentially flat sales of US$880 million year on year but a swing from a US$20 million net profit to a US$10 million net loss, while also advancing its Return-to-Growth plan. At the same time, the company launched Smart View – Detect, the first FDA-cleared AI-enabled diagnostic aid for PARL detection in CBCT scans, and expanded its U.S. digital dentistry reach through an enhanced distribution agreement with Atlanta Dental Supply. We’ll now...

Why this quarter matters for Mercury Systems stock Mercury Systems (MRCY) has drawn fresh attention after third quarter results topped earnings and revenue expectations, accompanied by record bookings, record backlog, stronger adjusted EBITDA, and a smaller net loss than a year earlier. See our latest analysis for Mercury Systems. The latest quarterly beat has coincided with a clear upswing in momentum, with a 5.64% 1 day share price return and an 11.78% 30 day share price return, while 1...

FDA approves Jakafi XR extended-release tablets for myelofibrosis, polycythemia vera and graft-versus-host disease. Jakafi XR offers a once-daily dosing option that differs from existing formulations of ruxolitinib. The approval expands Incyte's Jakafi franchise and broadens its treatment toolkit across several serious blood and immune conditions. For investors watching NasdaqGS:INCY, this latest approval sits at the heart of the company’s core focus in hematology and oncology. Jakafi has...